scholarly journals UPAYA PEMERINTAH DAERAH DALAM PENANGANAN PANDEMI COVID-19 DI KABUPATEN GARUT

Author(s):  
Rana Putri Kurniawan ◽  
Muhammad Alvin Giffary ◽  
Wendy Marbun

The pandemic that is endemic throughout the world is making every country work hard to eradicate it. has been declared by the World Health Organization (WHO) as a Global Public Health Emergency which is known to spread to all corners of the world very quickly. Coronavirus is a new virus that causes illness ranging from mild to severe symptoms. There are at least two types of corona viruses that cause serious illness, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Coronavirus disease 2019 (COVID-19) is a new disease that has never been identified in humans. The virus that causes is called SarsCoV2. COVID-19 is a new disease and there is very little research on it. Evidence-based information is required for the care, treatment and other information related to this disease. The Indonesian government later declared the Corona problem as an unnatural or non-natural national disaster. The President of the Republic of Indonesia, regional governments and their staff work together in various efforts to prevent the spread of the virus in the community. From ministerial level to province, district or city Keywords: Pandemic, Local Government, Efforts  

2021 ◽  
Vol 15 ◽  
pp. 183-208
Author(s):  
Diana Mazepa

Koniec 2019 r. przyniósł doniesienia o pojawieniu się nowej choroby w Chinach. Pod koniec roku pierwsze infekcje SARS‑CoV‑2 odnotowano w prowincji Hubei, a w styczniu zaczęła pojawiać się w innych regionach świata, w tym w Europie. Dnia 11 III 2020 r. Światowa Organizacja Zdrowia (WHO) ogłosiła nową chorobę jako pandemię. Koronawirus uwidocznił luki i niedoskonałości systemów państwowych niezależnie od szerokości geograficznej i pozycji na świecie. Aby uporać się z rozprzestrzeniającym się wirusem, a jednocześnie zapobiec upadkom gospodarczym i społecznym, państwa nałożyły na obywateli liczne ograniczenia. W podobnej sytuacji znajdowała się również Macedonia Północna, a celem niniejszego artykułu jest przedstawienie sytuacji w kontekście inicjatyw rządowych podejmowanych w okresie od stycznia 2020 r. do czerwca 2021 r. Government initiatives of the Republic of North Macedonia during coronavirus pandemic – selected issues The end of 2019 brought reports of a new disease emerging in China. At the end of the year, the first SARS‑CoV‑2 infections were recorded in the Hubei province, and in January it began to appear in other regions of the world, including Europe. On 11 III 2020, the World Health Organization (WHO) declared the new disease as a pandemic. The coronavirus highlighted the vulnerabilities and imperfections of state systems regardless of latitude and world position. In order to deal with the spreading virus and at the same time to prevent economic and social collapses, states imposed numerous restrictions on citizens. North Macedonia was also in the same situation, and the purpose of this article is to present the situation in the context of government initiatives taken in the period from January 2020 to June 2021.


2020 ◽  
Author(s):  
Mujib Ullah

UNSTRUCTURED Coronaviruses belong to a large family of viruses. Coronavirus also called COVID-19 is a new disease that has not been previously identified in humans. The World Health Organization has announced that COVID-19 is a pandemic. Currently there is no specific vaccine or treatment for COVID-19. Current treatment for COVID-19 is only supportive (treating the symptoms). There are no antiviral or vaccine options at this time. Therefore, it is time to bring collective efforts to treat or prevent a rapidly evolving pandemic of COVID-19.


2021 ◽  
pp. 19-23
Author(s):  
Donizete Tavares Da Silva ◽  
Priscila De Sousa Barros Lima ◽  
Renato Sampaio Mello Neto ◽  
Gustavo Magalhães Valente ◽  
Débora Dias Cabral ◽  
...  

In March 2020, the World Health Organization (1) declared COVID-19 as a pandemic and a threat to global public health (2). The virus mainly affects the lungs and can cause acute respiratory distress syndrome (ARDS). In addition, coronavirus 2 severe acute respiratory syndrome (SARSCOV2) also has devastating effects on other important organs, including the circulatory system, brain, gastrointestinal tract, kidneys and liver


2014 ◽  
Vol 27 (3) ◽  
pp. 511-529 ◽  
Author(s):  
Sudeepa Abeysinghe

ArgumentScientific uncertainty is fundamental to the management of contemporary global risks. In 2009, the World Health Organization (WHO) declared the start of the H1N1 Influenza Pandemic. This declaration signified the risk posed by the spread of the H1N1 virus, and in turn precipitated a range of actions by global public health actors. This article analyzes the WHO's public representation of risk and examines the centrality of scientific uncertainty in the case of H1N1. It argues that the WHO's risk narrative reflected the context of scientific uncertainty in which it was working. The WHO argued that it was attempting to remain faithful to the scientific evidence, and the uncertain nature of the threat. However, as a result, the WHO's public risk narrative was neither consistent nor socially robust, leading to the eventual contestation of the WHO's position by other global public health actors, most notably the Council of Europe. This illustrates both the significance of scientific uncertainty in the investigation of risk, and the difficulty for risk managing institutions in effectively acting in the face of this uncertainty.


2020 ◽  

In the past 100 years, the world has faced four distinctly different pandemics: the Spanish flu of 1918-1919, the SARS pandemic of 2003, the H1N1 or “swine flu” pandemic of 2012, and the ongoing COVID-19 pandemic. Each public health crisis exposed specific systemic shortfalls and provided public health lessons for future events. The Spanish flu revealed a nursing shortage and led to a great appreciation of nursing as a profession. SARS showed the importance of having frontline clinicians be able to work with regulators and those producing guidelines. H1N1 raised questions about the nature of a global organization such as the World Health Organization in terms of the benefits and potential disadvantages of leading the fight against a long-term global public health threat. In the era of COVID-19, it seems apparent that we are learning about both the blessing and curse of social media.


2020 ◽  
Vol 3 (3) ◽  
pp. 01-02
Author(s):  
Khadiga Ismail

COVID-19 has high transmissibility and infectivity among human. On January 30, 2020, the World Health Organization (WHO) in an effort to slow down the global spread of the virus declared the outbreak, “A global public health emergency of international concern". The skin manifestations of the novel coronavirus COVID-19 were not recognized at the early stages of the pandemic but have received much recent attention in scientific journals. Reported manifestations range from pseudo-chilblains to a morbilliform (measles-like) exanthem, urticaria, vesicular eruptions, a dengue-like petechial rash and ovate scaling macules, and plaques mimicking pityriasis rosea.


2011 ◽  
Vol 20 (2) ◽  
pp. 290-297 ◽  
Author(s):  
TIKKI PANG

“I want my leadership to be judged by the impact of our work on the health of two populations: women and the people of Africa.” This is how Dr. Margaret Chan, the current Director-General of the World Health Organization (WHO), described her leadership mission. The reason behind this mission is evident. Women and girls constitute 70% of the world’s poor and 80% of the world’s refugees. Gender violence against women aged 15–44 is responsible for more deaths and disability than cancer, malaria, traffic accidents, and war. An estimated 350,000 to 500,000 women still die in childbirth every year. The negative health implications of absolute poverty are worst in Sub-Saharan Africa and South Asia. Hence, Chan aims to have the biggest impact on the world’s poorest people.


2020 ◽  
Vol 17 (1) ◽  
pp. 261-290 ◽  
Author(s):  
Steven A. Solomon ◽  
Claudia Nannini

Participation in the World Health Organization (WHO) is a multifaceted matter and should be understood as not only referring to the governance of WHO, but also to its scientific and technical work as well as its collaborative efforts towards advancing global public health more generally. The article is concerned, in particular, with the legal and political framework surrounding attendance and participation of states and various entities in the governing bodies of the Organization, at the global and regional level. It shows that participation in the governance of WHO is still today a domain reserved to the determination of its Member States. At the same time, solutions have been found and continued efforts are necessary to take into account geopolitical considerations and to ensure a meaningful and inclusive participation of all relevant actors in global health discussions.


2020 ◽  
Vol 41 (1) ◽  
pp. 45 ◽  
Author(s):  
John S Mackenzie ◽  
David W Smith

At the end of December, 2019, a new disease of unknown aetiology appeared in Wuhan, China. It was quickly identified as a novel betacoronavirus, and related to SARS-CoV and a number of other bat-borne SARS-like coronaviruses. The virus rapidly spread to all provinces in China, as well as a number of countries overseas, and was declared a Public Health Emergency of International Concern by the Director-General of the World Health Organization on 30 January 2020. This paper describes the evolution of the outbreak, and the known properties of the novel virus, SARS-CoV-2 and the clinical disease it causes, COVID-19, and comments on some of the important gaps in our knowledge of the virus and the disease it causes. The virus is the third zoonotic coronavirus, after SARS-CoV and MERS-CoV, but appears to be the only one with pandemic potential.


Author(s):  
Raiiq Ridwan ◽  
Md Robed Amin ◽  
Md Ridwanur Rahman

Since December 2019, when a cluster of atypical pneumonia cases were identified in Wuhan, China a new disease has spread across the world. COVID-19 has since become the biggest pandemic in a century, touching lives in almost every country in the world. At the outset of COVID-19, the World Health Organization advised for testing to become a priority so that patients with COVID-19 could be quickly identified, isolated and treated to interrupt transmission of disease. However, testing shortages have been an increasing problem in low and middle income countries. Even when tests are available, it has proved time-consuming. Therefore, we propose a symptom-based tool to assist in the diagnosis of COVID-19 management in low and middle income Countries. It is based on the symptoms that have so far been described in the literature and advises the frontline healthcare worker on how to diagnose the likelihood of having COVID-19 and separate the patient into Red (very likely), Yellow (possible) and Green (unlikely) categories. J Bangladesh Coll Phys Surg 2020; 38(0): 71-75


Sign in / Sign up

Export Citation Format

Share Document